Accelerate Diagnostics Inc (AXDX) - Financial and Strategic SWOT Analysis Review

  • ID: 1315495
  • SWOT Analysis
  • 41 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Becton Dickinson and Co
  • bioMerieux SA
  • Bruker Corporation
  • Danaher Corp
  • Luminex Corp
  • T2 Biosystems Inc
  • MORE
Accelerate Diagnostics Inc (AXDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Accelerate Diagnostics Inc (Accelerate) is an in vitro diagnostics company that undertakes the development and commercialization of instrumentation for identification and testing the antibiotic susceptibility of infectious pathogens. Its product portfolio includes Accelerate Pheno system, in vitro diagnostic platform for the identification (ID) and antibiotic susceptibility testing (AST) of infectious pathogens; and Accelerate PhenoTest BC kit which provides ID and AST results for patients suspected of bacteremia or fungemia. Accelerate uses its proprietary molecular identification methods and morphokinetic cellular analysis to provide faster quantitative ID/AST results. The company has a manufacturing facility in Tucson, Arizona. Accelerate is headquartered in Tucson, Arizona, the US.

Accelerate Diagnostics Inc Key Recent Developments

Feb 15, 2018: Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
Nov 16, 2017: Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors
Nov 02, 2017: Accelerate Diagnostics reports Q3 2017 financial results
Aug 03, 2017: Accelerate Diagnostics Reports Q2 2017 Financial Results, Doubles Revenue Generating Placements
Jul 31, 2017: Accelerate Diagnostics Welcomes Dr. Romney Humphries as Chief Scientific Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Becton Dickinson and Co
  • bioMerieux SA
  • Bruker Corporation
  • Danaher Corp
  • Luminex Corp
  • T2 Biosystems Inc
  • MORE
Section 1 - About the Company
  • Accelerate Diagnostics Inc - Key Facts
  • Accelerate Diagnostics Inc - Key Employees
  • Accelerate Diagnostics Inc - Key Employee Biographies
  • Accelerate Diagnostics Inc - Major Products and Services
  • Accelerate Diagnostics Inc - History
  • Accelerate Diagnostics Inc - Company Statement
  • Accelerate Diagnostics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • Accelerate Diagnostics Inc - Business Description
  • R&D Overview
  • Accelerate Diagnostics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Accelerate Diagnostics Inc - Strengths
  • Accelerate Diagnostics Inc - Weaknesses
  • Accelerate Diagnostics Inc - Opportunities
  • Accelerate Diagnostics Inc - Threats
  • Accelerate Diagnostics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Accelerate Diagnostics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Accelerate Diagnostics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Feb 15, 2018: Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
  • Nov 16, 2017: Accelerate Diagnostics Welcomes Dr. Charles Watts to its Board of Directors
  • Nov 02, 2017: Accelerate Diagnostics reports Q3 2017 financial results
  • Aug 03, 2017: Accelerate Diagnostics Reports Q2 2017 Financial Results, Doubles Revenue Generating Placements
  • Jul 31, 2017: Accelerate Diagnostics Welcomes Dr. Romney Humphries as Chief Scientific Officer
  • May 30, 2017: Accelerate Diagnostics announces sizeable release of data at ASM Microbe 2017
  • May 03, 2017: Accelerate Diagnostics Reports 191 Instruments Under Contract and 3x Revenue Growth for First Quarter 2017
  • Mar 15, 2017: Accelerate Diagnostics Names Tom Brown to Board of Directors
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Accelerate Diagnostics Inc, Key Facts
  • Accelerate Diagnostics Inc, Key Employees
  • Accelerate Diagnostics Inc, Key Employee Biographies
  • Accelerate Diagnostics Inc, Major Products and Services
  • Accelerate Diagnostics Inc, History
  • Accelerate Diagnostics Inc, Subsidiaries
  • Accelerate Diagnostics Inc, Key Competitors
  • Accelerate Diagnostics Inc, Ratios based on current share price
  • Accelerate Diagnostics Inc, Annual Ratios
  • Accelerate Diagnostics Inc, Annual Ratios
  • Accelerate Diagnostics Inc, Interim Ratios
  • Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Accelerate Diagnostics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018
  • Accelerate Diagnostics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Accelerate Diagnostics Inc, Performance Chart (2013 - 2017)
  • Accelerate Diagnostics Inc, Ratio Charts
  • Accelerate Diagnostics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018
  • Accelerate Diagnostics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • T2 Biosystems Inc
  • Luminex Corp
  • Danaher Corp
  • Bruker Corporation
  • bioMerieux SA
  • Becton Dickinson and Co
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll